GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Labcorp Holdings Inc (FRA:N6B) » Definitions » Price-to-Owner-Earnings

Labcorp Holdings (FRA:N6B) Price-to-Owner-Earnings : (As of May. 21, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Labcorp Holdings Price-to-Owner-Earnings?

As of today (2024-05-21), Labcorp Holdings's share price is €192.50. Labcorp Holdings does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Labcorp Holdings's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Labcorp Holdings was 119.40. The lowest was 8.78. And the median was 14.00.


FRA:N6B's Price-to-Owner-Earnings is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 25.11
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-21), Labcorp Holdings's share price is €192.50. Labcorp Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €4.60. Therefore, Labcorp Holdings's PE Ratio for today is 41.82.

As of today (2024-05-21), Labcorp Holdings's share price is €192.50. Labcorp Holdings's EPS without NRI for the trailing twelve months (TTM) ended in was €12.74. Therefore, Labcorp Holdings's PE Ratio without NRI for today is 15.11.

During the past 13 years, Labcorp Holdings's highest PE Ratio without NRI was 21.91. The lowest was 7.67. And the median was 14.95.


Labcorp Holdings Price-to-Owner-Earnings Historical Data

The historical data trend for Labcorp Holdings's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labcorp Holdings Price-to-Owner-Earnings Chart

Labcorp Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.89 17.97 10.75 16.61 120.00

Labcorp Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.04 45.17 54.24 120.00 -

Competitive Comparison of Labcorp Holdings's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Labcorp Holdings's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labcorp Holdings's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Labcorp Holdings's Price-to-Owner-Earnings falls into.



Labcorp Holdings Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Labcorp Holdings's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=192.50/-0.55
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labcorp Holdings  (FRA:N6B) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Labcorp Holdings Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Labcorp Holdings's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Labcorp Holdings (FRA:N6B) Business Description

Traded in Other Exchanges
Address
358 South Main Street, Burlington, NC, USA, 27215
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.

Labcorp Holdings (FRA:N6B) Headlines

No Headlines